[This is the initial public offering of our Class A common stock. We are selling 18,421,053 shares of our Class A common stock. The initial public offering price is $18.00 per share of Class A common stock. We have granted the underwriters an option to purchase up to 2,631,579 additional shares of Class A common stock. Upon consummation of this]
[This is the initial public offering of our Class A common stock. We are selling 18,421,053 shares of our Class A common stock. The initial public offering price is $18.00 per share of Class A common stock. We have granted the underwriters an option to purchase up to 2,631,579 additional shares of Class A common stock. Upon consummation of this]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[Mindray Medical International Limited (Mindray, NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 17, 2013. re-election At the meeting, Mindray shareholders approved the In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Companys independent registered public accounting]
[INDEX TO FINANCIAL STATEMENTS Use these links to rapidly review the document PROSPECTUS 18,421,053 Shares AMC Entertainments,Inc. ClassAmmon Stock $18.00 per share This is the initial public offering of our ClassAmmon stock. We are selling 18,421,053shares of our ClassAmmon stock. The initial public offering price is $18.00 per share of ClassAmmon stock.]
[INDEX TO FINANCIAL STATEMENTS Use these links to rapidly review the document PROSPECTUS 18,421,053 Shares AMC Entertainments,Inc. ClassAmmon Stock $18.00 per share This is the initial public offering of our ClassAmmon stock. We are selling 18,421,053shares of our ClassAmmon stock. The initial public offering price is $18.00 per share of ClassAmmon stock.]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): December 18, 2013 (December 12, 2013) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6889 ¨ ¨ ¨ ¨]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): December 18, 2013 (December 12, 2013) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6889 ¨ ¨ ¨ ¨]
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]
